Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • Investor Portal
    • JOIN OUR TEAM
    • Contact

NEWS

Our Latest News

ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products

Global private equity healthcare specialist ARCHIMED announces the acquisition of DermaPharm A/V. DermaPharm is a leading player in Nordic suncare and a world-renowned skincare contract development & manufacturing organization for third parties.

 

ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products

ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials

 May

 18, 

2020

Growth investment is set to accelerate Polyplus’ expansion in partnership with Warburg Pincus and ARCHIMED

 April

 29, 

2020

ARCHIMED’s Direct Healthcare Group acquires Patient Handling Europe

 April

 9, 

2020

ARCHIMED’s portfolio company DIESSE is developing a blood test for COVID-19 detection – it will be one of the first in the world capable of accurately mapping the spread of the virus

 March

 23, 

2020

ARCHIMED’s DHG completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB

 March

 3, 

2020

ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge

 December

 12, 

2019

< 1 … 10 11 12 13 14 … 18 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • Contact Us
  • Videos
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top